CALA logo

Calithera Biosciences (CALA) EBITDA

Annual EBITDA

-$41.82 M
+$22.46 M+34.94%

December 31, 2022

Summary

Performance

1-Year Change

+34.94%

3-Year Change

+54.75%

5-Year Change

-42.62%

15-Year Change

-42.62%

CALA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.38%
CALA annual EBITDA is higher than 35.38% of companies in Healthcare sector

High & Low

All-time High

-$7.71 M

3-Year Low

-$64.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CALA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CALA next annual earnings announcement has not yet been scheduled

OtherCALAprofitabilitymetrics:

Annual Revenue

-
CALA annual revenue value is unknown

Annual Net Income

-$39.65 M
CALA annual net profit is -$39.65 million

Annual EBIT

-$42.07 M
CALA annual earnings before interest & taxes is -$42.07 million

Annual EPS

-$7.94
CALA annual earnings per share is -$7.94

Quarterly EBITDA

-$7.28 M
+$2.18 M+23.07%

December 31, 2022

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

CALA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.03%
CALA quarterly EBITDA is higher than 42.03% of companies in Healthcare sector

High & Low

All-time High

-$3.25 M

3-Year Low

-$18.27 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAprofitabilitymetrics:

Quarterly Revenue

-
CALA quarterly revenue value is unknown

Quarterly Net Income

-$6.94 M
CALA quarterly net profit is -$6.94 million

Quarterly EBIT

-$7.35 M
CALA quarterly earnings before interest & taxes is -$7.35 million

Quarterly EPS

-$1.45
CALA quarterly earnings per share is -$1.45

TTM EBITDA

-$41.82 M
+$10.99 M+20.81%

December 31, 2022

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

CALA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.46%
CALA TTM EBITDA is higher than 35.46% of companies in Healthcare sector

High & Low

All-time High

-$3.25 M

3-Year Low

-$64.28 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAprofitabilitymetrics:

TTM Revenue

-
CALA TTM revenue value is unknown

TTM Net Income

-$39.65 M
CALA TTM net profit is -$39.65 million

TTM EBIT

-$42.07 M
CALA TTM earnings before interest & taxes is -$42.07 million

TTM EPS

-$8.65
CALA TTM earnings per share is -$8.65

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$41.82 M
CALA annual EBITDA is -$41.82 million

Annual Net Income

-$39.65 M
CALA annual net profit is -$39.65 million

Annual Interest Expense

-
CALA annual interest expense value is unknown

Annual Income Tax

-
CALA annual income tax value is unknown

Annual D&A

$255.00 K
CALA annual depreciation & amortization is $255.00 thousand

CALA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.9%0.0%0.0%
3 y3 years+54.8%0.0%0.0%
5 y5 years-42.6%0.0%0.0%

CALA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.9%at high+60.1%at high+34.9%
5 y5-yearat high+54.8%at high+70.8%at high+55.1%
alltimeall time-442.7%+54.8%-124.3%+70.8%-1188.3%+55.1%

Calithera Biosciences EBITDA History

DateAnnualQuarterlyTTM
Dec 2022
-$41.82 M(-34.9%)
-$7.28 M(-23.1%)
-$41.82 M(-20.8%)
Sep 2022
-
-$9.46 M(-16.3%)
-$52.81 M(-3.0%)
Jun 2022
-
-$11.31 M(-17.8%)
-$54.42 M(-5.1%)
Mar 2022
-
-$13.76 M(-24.7%)
-$57.35 M(-10.8%)
Dec 2021
-$64.28 M(-29.4%)
-$18.27 M(+64.9%)
-$64.28 M(-6.3%)
Sep 2021
-
-$11.08 M(-22.2%)
-$68.59 M(-14.6%)
Jun 2021
-
-$14.23 M(-31.2%)
-$80.32 M(-7.4%)
Mar 2021
-
-$20.69 M(-8.4%)
-$86.75 M(-4.7%)
Dec 2020
-$91.02 M(-1.5%)
-$22.58 M(-1.0%)
-$91.02 M(+0.3%)
Sep 2020
-
-$22.82 M(+10.4%)
-$90.78 M(+2.0%)
Jun 2020
-
-$20.66 M(-17.2%)
-$88.98 M(-4.4%)
Mar 2020
-
-$24.97 M(+11.8%)
-$93.10 M(+0.7%)
Dec 2019
-$92.42 M(+62.8%)
-$22.34 M(+6.3%)
-$92.42 M(+2.5%)
Sep 2019
-
-$21.01 M(-15.2%)
-$90.17 M(+1.8%)
Jun 2019
-
-$24.79 M(+2.1%)
-$88.54 M(+31.4%)
Mar 2019
-
-$24.28 M(+20.8%)
-$67.37 M(+18.7%)
Dec 2018
-$56.78 M
-$20.09 M(+3.7%)
-$56.78 M(+18.0%)
Sep 2018
-
-$19.38 M(+436.2%)
-$48.11 M(+36.3%)
Jun 2018
-
-$3.61 M(-73.6%)
-$35.30 M(-5.5%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$13.69 M(+19.7%)
-$37.33 M(+27.3%)
Dec 2017
-$29.32 M(-22.9%)
-$11.43 M(+74.2%)
-$29.32 M(+6.9%)
Sep 2017
-
-$6.56 M(+16.1%)
-$27.42 M(-6.8%)
Jun 2017
-
-$5.65 M(-0.4%)
-$29.42 M(-13.8%)
Mar 2017
-
-$5.68 M(-40.4%)
-$34.14 M(-10.2%)
Dec 2016
-$38.04 M(+17.3%)
-$9.53 M(+11.3%)
-$38.04 M(+4.1%)
Sep 2016
-
-$8.56 M(-17.5%)
-$36.55 M(-0.8%)
Jun 2016
-
-$10.37 M(+8.4%)
-$36.85 M(+7.7%)
Mar 2016
-
-$9.57 M(+19.0%)
-$34.23 M(+5.6%)
Dec 2015
-$32.41 M(+51.8%)
-$8.04 M(-9.2%)
-$32.41 M(+4.2%)
Sep 2015
-
-$8.86 M(+14.2%)
-$31.11 M(+13.6%)
Jun 2015
-
-$7.75 M(-0.0%)
-$27.39 M(+9.4%)
Mar 2015
-
-$7.76 M(+15.2%)
-$25.04 M(+17.2%)
Dec 2014
-$21.36 M(+76.6%)
-$6.73 M(+31.0%)
-$21.36 M(+14.6%)
Sep 2014
-
-$5.14 M(-5.0%)
-$18.64 M(+11.3%)
Jun 2014
-
-$5.41 M(+32.7%)
-$16.75 M(+47.7%)
Mar 2014
-
-$4.08 M(+1.5%)
-$11.34 M(+56.1%)
Dec 2013
-$12.10 M(+57.0%)
-$4.02 M(+23.8%)
-$7.26 M(+123.8%)
Sep 2013
-
-$3.25 M
-$3.25 M
Dec 2012
-$7.71 M
-
-

FAQ

  • What is Calithera Biosciences annual EBITDA?
  • What is the all time high annual EBITDA for Calithera Biosciences?
  • What is Calithera Biosciences annual EBITDA year-on-year change?
  • What is Calithera Biosciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Calithera Biosciences?
  • What is Calithera Biosciences quarterly EBITDA year-on-year change?
  • What is Calithera Biosciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Calithera Biosciences?
  • What is Calithera Biosciences TTM EBITDA year-on-year change?

What is Calithera Biosciences annual EBITDA?

The current annual EBITDA of CALA is -$41.82 M

What is the all time high annual EBITDA for Calithera Biosciences?

Calithera Biosciences all-time high annual EBITDA is -$7.71 M

What is Calithera Biosciences annual EBITDA year-on-year change?

Over the past year, CALA annual EBITDA has changed by +$22.46 M (+34.94%)

What is Calithera Biosciences quarterly EBITDA?

The current quarterly EBITDA of CALA is -$7.28 M

What is the all time high quarterly EBITDA for Calithera Biosciences?

Calithera Biosciences all-time high quarterly EBITDA is -$3.25 M

What is Calithera Biosciences quarterly EBITDA year-on-year change?

Over the past year, CALA quarterly EBITDA has changed by $0.00 (0.00%)

What is Calithera Biosciences TTM EBITDA?

The current TTM EBITDA of CALA is -$41.82 M

What is the all time high TTM EBITDA for Calithera Biosciences?

Calithera Biosciences all-time high TTM EBITDA is -$3.25 M

What is Calithera Biosciences TTM EBITDA year-on-year change?

Over the past year, CALA TTM EBITDA has changed by $0.00 (0.00%)